Navigation Links
PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
Date:1/4/2008

BOSTON, Jan. 4 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release Second Quarter Fiscal Year 2008 financial results on Wednesday, January 23, 2008 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com and on the PR Newswire website at http://www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, January 24, 2008 to discuss the results. To access the webcast, visit PAREXEL's website at http://www.parexel.com, click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (612) 332-0107 and ask to join PAREXEL's Second Quarter Fiscal Year 2008 conference call.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical developm
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 20, 2014 The report, ... Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, ... Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to ... drivers, threats, opportunities, and challenges. , Browse ... spread through 185 pages and in-depth TOC ...
(Date:11/21/2014)... Why did Stephen Hawking become so famous? ... recognizable? Why have they become icons to rival film ... Ratcliffe seeks out the answers to those questions, and ... with science. In " Stephen Hawking Smoked My Socks ... Ratcliffe puts it plainly: , “It is profoundly ...
(Date:11/21/2014)... Polaris Group announced today that the ... 1 trial of ADI-PEG 20 in combination with ... pleural mesothelioma (MPM) and non-squamous non-small cell lung ... ADI-PEG 20, both as monotherapy and in combination ... other indications, including breast cancer, melanomas, ovarian cancer, ...
(Date:11/21/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results ... 2014.  Biorem,s complete 2014 third quarter financial statements and MD&A have ... ended September 30, , Nine-months ended September ... 2014 , 2013 , 2014 , ... , 6,715 , 14,476 Gross profit , ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... - There are several reasons why Deb Rislow believes she ... of information systems for Gundersen Lutheran - at ... been a hotter topic as the federal government tries to ... to reduce medical errors, control costs, and improve care. , ...
... It would be impressive enough if the robotics engineering ... Park, Minn., had won a national championship against other ... competitors were seasoned college students. , ,Led by instructor ... graduate-level college students in the 2005 U.S. Open RoboCup. ...
... the United States Supreme Court strengthened the case ... Foundation? , ,The answer is yes, according to the California ... not necessarily a consensus opinion. , ,The nation's high court, ... Appeals for the Federal Circuit , ruled in favor of ...
Cached Biology Technology:CIO Leadership Series: Deb Rislow, Gundersen Lutheran 2CIO Leadership Series: Deb Rislow, Gundersen Lutheran 3CIO Leadership Series: Deb Rislow, Gundersen Lutheran 4CIO Leadership Series: Deb Rislow, Gundersen Lutheran 5Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4Supreme Court ruling seen as blow to WARF stem cell patents 2Supreme Court ruling seen as blow to WARF stem cell patents 3
(Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still ... Doctor McCoy used in "Star Trek" to gain instant access ... designed to work with smartphones and tablets for monitoring and ... the healthcare world. This may seem a tad Orwellian to ... to adopt some of these technological opportunities into their healthcare ...
(Date:11/7/2014)... led by Dr. Debra Auguste, associate professor, biomedical ... The City College of New York, have identified ... for one of the most aggressive forms of ... have a high mortality rate owing to aggressive ... therapeutic options. However, Professor Auguste,s team, discovered the ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... allowed patients suffering from musculoskeletal conditions such as hip ... pain-free. But some "high risk" surgical devices that have ... (FDA) are not required to go through clinical trials, ... and effectiveness. "This could be potentially very dangerous. ...
... could provide the link that scientists have been looking for ... a cause of some heart problems. Looking at blood ... found that those who had suffered a heart attack were ... blood compared to patients with less acute symptoms. And having ...
... of silicon react with water to produce hydrogen almost ... a series of experiments, the scientists created spherical silicon ... water, these particles reacted to form silicic acid (a ... energy for fuel cells. The reaction didn,t require ...
Cached Biology News:A call to prevent unsafe high-risk medical devices from reaching the marketplace 2A call to prevent unsafe high-risk medical devices from reaching the marketplace 3Study: Viral reactivation a likely link between stress and heart disease 2Study: Viral reactivation a likely link between stress and heart disease 3Just add water: How scientists are using silicon to produce hydrogen on demand 2
Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
... Glucagon-like peptide-1(7-36) amide (GLP-1), C-terminal reactive. ... shows <0.1% cross reactivity with the ... other related peptides such as hGLP-2, ... mammalian species. GLP-1 is identical in ...
Human/Mouse/Rat AMPK beta 1 Affinity Purified Polyclonal Ab...
Biology Products: